Q32 Bio Inc. (QTTB) EPS (Basic) (2017 - 2026)

Q32 Bio has reported EPS (Basic) for 10 years, with the latest figure at -$0.44 in Q2 2026.

• On a quarterly basis, EPS (Basic) rose 43.47% year-over-year to -$0.44 in Q2 2026; TTM through Jun 2026 was $0.2, a 151.86% increase from a year earlier, with the FY2025 full-year figure at $0.0, up 147.34% from the prior year.
• EPS (Basic) was -$0.44 for Q2 2026 at Q32 Bio, up from -$0.54 in the prior quarter.
• The five-year high for EPS (Basic) was $29.12 in Q1 2022, with the low at -$9.91 in Q3 2022.
• Average EPS (Basic) over 5 years is $0.08, with a median of -$0.84 recorded in 2025.
• The sharpest annual moves came in 2022 and 2025: EPS (Basic) surged 7693.12% in 2022, then plunged 187.47% in 2025.
• Over 5 years, EPS (Basic) stood at -$9.68 in 2022, then soared by 185.62% to $8.29 in 2023, then tumbled by 56.62% to $3.59 in 2024, then sank by 36.8% to $2.27 in 2025, then sank by 119.36% to -$0.44 in 2026.
• The last three EPS (Basic) figures came in at -$0.44 (Q2 2026), -$0.54 (Q1 2026), and $2.27 (Q4 2025), per Business Quant data.